Today: 27 March 2026
Subscribe
Browse Category

Stock Market 18 February 2026

RELX share price slips as buyback and insider filings hit the tape

RELX share price slips as buyback and insider filings hit the tape

RELX shares fell 2% to 2,180 pence in early London trading after routine filings showed buyback activity and executive share sales. The company bought 1.8 million shares on Feb. 17 as part of a £450 million repurchase program. CEO Erik Engstrom sold 22,000 shares on Feb. 13. Investors await further company documents and updates on the buyback schedule.
18 February 2026
·
Glencore share price rises on $2 billion payout plan as Congo copper deal grabs attention

Glencore share price rises on $2 billion payout plan as Congo copper deal grabs attention

Glencore shares rose about 3% in early London trade after announcing a $2 billion shareholder payout and full-year results. The board proposed a $0.17-per-share cash distribution in two tranches, pending a May 28 AGM vote. Glencore also finalized a land-access deal for its Congo copper mine, aiming to extend its life into the 2040s. Adjusted EBITDA fell 6% to $13.51 billion, beating analyst expectations.
18 February 2026
···
BAE Systems share price jumps 6% after profit rise, record backlog and dividend lift

BAE Systems share price jumps 6% after profit rise, record backlog and dividend lift

BAE Systems shares jumped 6.2% in early London trading after reporting a 12% rise in underlying operating profit and a record £83.6 billion order backlog. 2025 sales climbed 10% to £30.7 billion, but free cash flow dropped to £2.16 billion. The company raised its dividend 10% and repurchased 30 million shares. Investors await a 09:30 GMT presentation for more detail on cash and margins.
18 February 2026
··
Evolution Mining share price slides for fifth day as gold whipsaws; what to watch next

Evolution Mining share price slides for fifth day as gold whipsaws; what to watch next

Evolution Mining shares fell 2.2% to A$14.59 in Sydney, marking a fifth straight session of losses and leaving the stock 10% below last week’s record. Gold rebounded 1.1% to $4,931.61 an ounce after a sharp drop, ahead of U.S. Federal Reserve minutes. Investors are watching Evolution’s March 3 ex-dividend date and April 15 quarterly results for further direction.
18 February 2026
···
Fortescue share price edges up as Wyloo North mine faces public comment, with results next week

Fortescue share price edges up as Wyloo North mine faces public comment, with results next week

Fortescue shares closed up 0.5% at A$20.20 Wednesday as Western Australia’s EPA opened a week-long public comment period for the proposed Wyloo North iron ore mine. The EPA described the project as a 13-year open-cut operation with groundwater pumping and up to 4,954.5 hectares of disturbance. Investors await the Feb. 23 comment deadline and Fortescue’s half-year results on Feb. 25.
18 February 2026
··
Pro Medicus share price drops again as insiders buy — what ASX:PME traders watch next

Pro Medicus share price drops again as insiders buy — what ASX:PME traders watch next

Pro Medicus shares fell 2.35% to A$123.00 Wednesday, extending a 43% drop for 2026 despite the S&P/ASX 200 closing higher. Directors Anthony Glenning and Deena Shiff bought shares on Feb. 13. The company reported half-year revenue of A$124.8 million and statutory profit after tax of A$171.2 million, boosted by a fair-value gain. Pro Medicus declared a 32-cent interim dividend, ex-dividend Feb. 26, payable March 20.
18 February 2026
··
BlueScope Steel (ASX:BSL) share price jumps on revised SGH takeover offer — what investors watch next

BlueScope Steel (ASX:BSL) share price jumps on revised SGH takeover offer — what investors watch next

BlueScope Steel shares rose 2.6% to A$28.74 after confirming it is reviewing a revised A$32.35 per share cash takeover proposal from SGH and Steel Dynamics. The offer remains about 11% above the closing price, reflecting market doubts. BlueScope posted first-half net profit of A$391 million and forecast higher earnings, while the board said no action is required and there is no certainty of a deal.
18 February 2026
····
Macquarie share price ends higher after $685 million IHS tower deal — what MQG investors watch next

Macquarie share price ends higher after $685 million IHS tower deal — what MQG investors watch next

Macquarie shares closed up 0.6% at A$219.60 after its asset management arm agreed to buy IHS Towers’ South American tower portfolio for $685 million. The deal is expected to close later in 2026. IHS Towers is exiting Latin America and said the portfolio includes about 8,860 sites. Macquarie’s next major event is its full-year results on May 8.
18 February 2026
··
BHP share price slips after record rally as dividend dates and copper shift grab focus

BHP share price slips after record rally as dividend dates and copper shift grab focus

BHP Group fell 0.9% to A$52.29 in Sydney on Wednesday, retreating after a record-high surge on Tuesday following a half-year profit and dividend beat. The miner set an interim dividend of 73 U.S. cents, with an ASX ex-dividend date of March 5. Investors weighed a $4.3 billion silver streaming deal and rising copper guidance against weaker iron ore prices. The S&P/ASX 200 rose 0.5% as materials lagged.
18 February 2026
··
1 … 92 93 94 95 96 … 1,365

Stock Market Today

  • Kaken Pharmaceutical Faces Valuation Questions Amid Muted Share Momentum
    March 27, 2026, 5:07 AM EDT. Kaken Pharmaceutical (TSE:4521) has shown muted share price momentum recently, with a 3-month gain of just 2.3% and a year-to-date return of 5.11%. Trading at ¥4,220, the stock's price-to-sales (P/S) ratio stands at 2.1x, above the estimated fair P/S of 1.5x and peer average of 1.2x, highlighting a potential overvaluation. The company remains unprofitable, with annual revenue contracting 1.9%, raising concerns over its ability to justify the premium valuation. A discounted cash flow (DCF) model estimates a fair value of ¥3,860.63, suggesting shares trade rich versus fundamentals. Investors face a key question: is the market pricing in future growth beyond current earnings? Recent mixed returns and a valuation premium suggest caution amid uncertain earnings prospects.
Go toTop